[{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"5f60b137-472e-4b9d-8c47-3fd52ad8cd05","codeSystem":"CAS","code":"736992-21-5","type":"PRIMARY","url":"https://commonchemistry.cas.org/detail?cas_rn=736992-21-5","_isClassification":false,"references":["81cc373d-e7f9-4246-866b-84313d0a7fb6","bae88ebe-210b-4083-8183-fd111475ccaa"],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"c295db52-7eb9-4f2e-9e45-8e9a9c02f4a6","codeSystem":"INN","code":"10154","type":"PRIMARY","url":"https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=10154","_isClassification":false,"references":["81cc373d-e7f9-4246-866b-84313d0a7fb6"],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"d63ae43a-d437-403b-a0ec-8d7ee9d93e8d","codeSystem":"PUBCHEM","code":"11764719","type":"PRIMARY","url":"https://pubchem.ncbi.nlm.nih.gov/compound/11764719","_isClassification":false,"references":["81cc373d-e7f9-4246-866b-84313d0a7fb6"],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"4470d403-2d7a-42c9-d1f9-0cd954e1f77f","codeSystem":"EPA CompTox","code":"DTXSID50471988","type":"PRIMARY","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID50471988","_isClassification":false,"references":["07831d43-b16e-d6d7-3b7b-4179db84fa38"],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"33ba2818-6eb0-b30b-1aed-6e7e0766b171","codeSystem":"FDA ORPHAN DRUG","code":"597417","comments":"ORPHAN DRUG|Designated|Treatment of primary mitochondrial myopathy","type":"PRIMARY","url":"https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=597417","_isClassification":true,"references":[],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"a3a179e7-0cd0-5e24-d99c-70e65c19f170","codeSystem":"FDA ORPHAN DRUG","code":"609417","comments":"ORPHAN DRUG|Designated|Treatment of Leber’s Hereditary Optic Neuropathy","type":"PRIMARY","url":"https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=609417","_isClassification":true,"references":[],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"b46417cb-ede7-7b4a-1112-cb30de7460c6","codeSystem":"FDA ORPHAN DRUG","code":"607817","comments":"ORPHAN DRUG|Designated|Treatment of Barth syndrome","type":"PRIMARY","url":"https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=607817","_isClassification":true,"references":[],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"c13dc768-50e1-dec3-bcba-fd117db90947","codeSystem":"NCI_THESAURUS","code":"C171874","type":"PRIMARY","url":"https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C171874","_isClassification":false,"references":["59b735ea-a90d-169a-fe19-9557a07dd826"],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"cb6345a8-f8ad-4da7-84df-e8f382b52a54","codeSystem":"FDA UNII","code":"87GWG91S09","type":"PRIMARY","_isClassification":false,"references":[],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"048fbea7-9a87-6338-9488-228960e4dda2","codeSystem":"DRUG BANK","code":"DB11981","type":"PRIMARY","url":"https://go.drugbank.com/drugs/DB11981","_isClassification":false,"references":["8eb22adf-3813-737c-0bd6-189d9de525f8"],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"01c95b5c-0c17-bd1e-70e2-e5e0c356ebd4","codeSystem":"USAN","code":"DE-80","type":"PRIMARY","url":"https://searchusan.ama-assn.org/finder/usan/search/DE-80/relevant/1/","_isClassification":false,"references":["2fbb5bba-1ca9-7e98-d16c-69ceee2dffd8"],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"b0b9d68e-06fe-71e7-a621-7df0cf526ef4","codeSystem":"WIKIPEDIA","code":"Elamipretide","type":"PRIMARY","url":"https://en.wikipedia.org/wiki/Elamipretide","_isClassification":false,"references":["463c252c-0716-7b25-3fa5-de3c7d1651f2"],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"c3129e0f-d221-5b09-70c9-473102fc6060","codeSystem":"FDA ORPHAN DRUG","code":"794420","comments":"ORPHAN DRUG|Designated|Treatment of Friedreich’s ataxia (FRDA)","type":"PRIMARY","url":"https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=794420","_isClassification":true,"references":["8eb22adf-3813-737c-0bd6-189d9de525f8"],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"931ac497-9c84-881a-9f49-14e92150712a","codeSystem":"SMS_ID","code":"100000174211","type":"PRIMARY","_isClassification":false,"references":["36dad24e-00d4-3f8a-7f67-95c64a1281a1"],"access":[]},{"created":1786366581515,"createdBy":"ADMIN","lastEdited":1786366581515,"lastEditedBy":"ADMIN","deprecated":false,"uuid":"448b0ccb-3756-e6a4-ae09-c14a75c5bede","codeSystem":"DAILYMED","code":"87GWG91S09","type":"PRIMARY","url":"https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=(87GWG91S09)","_isClassification":false,"references":["103f2756-a1a8-38d0-7ee6-9c6b228d489c"],"access":[]}]